科凯集团 KEY 深 沪
交易中 05-11 10:37:24 美东时间
21.575
-0.030
-0.14%
华盛通- 最 高22.425
- 今 开21.705
- 成交量 96.75万股
- 最 低 21.462
- 昨 收 21.605
- 总市值 2010.79万
- 52周最高 23.345
- 市盈率 静 8.20
- 换手率 103.81%
- 52周最低 15.28
- 委 比 84.08%
- 总股本 0.01亿
- 历史最高 26.78
- 量 比 0.80
- 振 幅 4.46%
- 历史最低 0.76
- 每 手 1
- 风险率 1.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For April 16, 2026
Companies Reporting Before The Bell • Marsh (NYSE:MRSH) is estimated to report ...
04-16 19:11
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
KeyCorp Files Prospectus Supplement Registering 161,968,762 Common Shares
On December 23, 2025, KeyCorp (the "Company") filed a prospectus supplement to its Registration Statement on Form S-3 (No. 333-272573) (the "Registration Statement") filed with the U.S. Securities and Exchange Commission
2025-12-24 05:47
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.
2025-11-17 23:47
对无人区说不，大药拿下百亿市场独占权
原标题：对无人区说不，大药拿下百亿市场独占权 复宏汉霖PD-1抗体H药再次大超预期。 过去H药另辟蹊径，凭借在一线广泛期小细胞肺癌（ES-SCLC）创历史的...
2025-10-16 08:02
复宏汉霖开创胃癌围手术期免疫单药治疗新时代 市场潜力超60亿美元H药独占先机
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月9日，复宏汉霖宣布其自主研发的PD-1抑制剂H药（斯鲁利单抗）胃癌围手...
2025-10-14 15:22
K药、O药折戟，H药成功登顶！全球首个胃癌免化疗方案即将诞生
（来源：求实药社） 在K药、O药都失败的领域，H药成功了。 复宏汉霖10月9日宣布H药汉斯状（PD-1单抗）胃癌围手术期III期临床研究达到主要终点，支持提前申...
2025-10-13 12:01
复宏汉霖IO大药又拿全球第一
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：阿基米德Biotech 在K药、O药都失败的领域，H药成功了。 复宏汉...
2025-10-13 08:03
中民控股遭LOFTY KEY LIMITED增持200万股 每股均价0.031港元
香港联交所最新资料显示，10月8日，LOFTY KEY LIMITED增持中民控股（00681）200万股，每股均价0.031港元，总金额约为6.2万港元...
2025-10-11 07:45
复宏汉霖：HLX17完成首例患者给药
复宏汉霖公告，公司自主研发的帕博利珠单抗生物类似药HLX17（重组抗PD-1人源化克隆抗体注射液）在多种已切除实体瘤患者中开展的国际多中心1期临床研究于中国境内...
2025-09-26 17:41
公司简介
公司名称
|
科凯集团
|
行业分类
|
--
|
业务描述
|
科凯集团的历史可以追溯到190多年以前，总部设在美国俄亥俄州克里夫兰市。作为全美最大的以银行为基础的金融服务公司，其资产总额接近1360亿美元。
科凯集团以KeyBank NA的名义为个人和小企业提供存款，贷款，现金管理和投资服务。科凯集团以KeyBanc资本市场商号在美国选定行业提供范围广泛的复杂企业及投资银行产品，如合并与收购咨询，公共和私人债务和股本，银团贷款以及中间市场公司衍生工具。
|
Earnings Scheduled For April 16, 2026
Companies Reporting Before The Bell • Marsh (NYSE:MRSH) is estimated to report ...
04-16 19:11
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
KeyCorp Files Prospectus Supplement Registering 161,968,762 Common Shares
On December 23, 2025, KeyCorp (the "Company") filed a prospectus supplement to its Registration Statement on Form S-3 (No. 333-272573) (the "Registration Statement") filed with the U.S. Securities and Exchange Commission
2025-12-24 05:47
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.
2025-11-17 23:47
对无人区说不，大药拿下百亿市场独占权
原标题：对无人区说不，大药拿下百亿市场独占权 复宏汉霖PD-1抗体H药再次大超预期。 过去H药另辟蹊径，凭借在一线广泛期小细胞肺癌（ES-SCLC）创历史的...
2025-10-16 08:02
复宏汉霖开创胃癌围手术期免疫单药治疗新时代 市场潜力超60亿美元H药独占先机
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月9日，复宏汉霖宣布其自主研发的PD-1抑制剂H药（斯鲁利单抗）胃癌围手...
2025-10-14 15:22
K药、O药折戟，H药成功登顶！全球首个胃癌免化疗方案即将诞生
（来源：求实药社） 在K药、O药都失败的领域，H药成功了。 复宏汉霖10月9日宣布H药汉斯状（PD-1单抗）胃癌围手术期III期临床研究达到主要终点，支持提前申...
2025-10-13 12:01
复宏汉霖IO大药又拿全球第一
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：阿基米德Biotech 在K药、O药都失败的领域，H药成功了。 复宏汉...
2025-10-13 08:03
中民控股遭LOFTY KEY LIMITED增持200万股 每股均价0.031港元
香港联交所最新资料显示，10月8日，LOFTY KEY LIMITED增持中民控股（00681）200万股，每股均价0.031港元，总金额约为6.2万港元...
2025-10-11 07:45
复宏汉霖：HLX17完成首例患者给药
复宏汉霖公告，公司自主研发的帕博利珠单抗生物类似药HLX17（重组抗PD-1人源化克隆抗体注射液）在多种已切除实体瘤患者中开展的国际多中心1期临床研究于中国境内...
2025-09-26 17:41
派息除权日
|
每股总股息
| 派息日期 |
2022-05-27
|
0.19
|
2022-06-15
|
2022-02-28
|
0.19
|
2022-03-15
|
2021-11-29
|
0.19
|
2021-12-15
|
2021-08-30
|
0.19
|
2021-09-15
|
2021-05-28
|
0.19
|
2021-06-15
|
2021-03-01
|
0.19
|
2021-03-15
|
2020-11-30
|
0.19
|
2020-12-15
|
2020-08-31
|
0.19
|
2020-09-15
|
2020-06-01
|
0.19
|
2020-06-15
|
2020-03-02
|
0.19
|
2020-03-13
|
2019-12-02
|
0.19
|
2019-12-13
|
2019-08-26
|
0.19
|
2019-09-13
|
2019-05-24
|
0.17
|
2019-06-14
|
2019-03-04
|
0.17
|
2019-03-15
|
2018-11-26
|
0.17
|
2018-12-14
|
2018-08-27
|
0.17
|
2018-09-14
|
2018-05-25
|
0.12
|
2018-06-15
|
2018-02-26
|
0.10
|
2018-03-15
|
2017-11-27
|
0.10
|
2017-12-15
|
2017-08-25
|
0.09
|
2017-09-15
|
2017-05-25
|
0.09
|
2017-06-15
|
2017-02-24
|
0.09
|
2017-03-15
|
2016-11-25
|
0.09
|
2016-12-15
|
2016-07-27
|
0.09
|
2016-09-15
|
2016-05-26
|
0.09
|
2016-06-15
|
2016-02-26
|
0.08
|
2016-03-15
|
2015-11-27
|
0.08
|
2015-12-15
|
2015-08-28
|
0.08
|
2015-09-15
|
2015-05-29
|
0.08
|
2015-06-15
|
2015-02-27
|
0.06
|
2015-03-13
|
2014-11-28
|
0.06
|
2014-12-15
|
2014-08-28
|
0.06
|
2014-09-15
|
2014-05-22
|
0.06
|
2014-06-13
|
2014-02-28
|
0.05
|
2014-03-14
|
2013-11-29
|
0.05
|
2013-12-13
|
2013-08-23
|
0.05
|
2013-09-13
|
2013-05-23
|
0.05
|
2013-06-14
|
2013-03-01
|
0.05
|
2013-03-15
|
2012-11-23
|
0.05
|
2012-12-14
|
2012-08-24
|
0.05
|
2012-09-14
|
2012-05-24
|
0.05
|
2012-06-15
|
2012-02-24
|
0.03
|
2012-03-15
|
2011-11-25
|
0.03
|
2011-12-15
|
2011-08-26
|
0.03
|
2011-09-15
|
2011-02-25
|
0.010
|
2011-03-15
|
2010-11-26
|
0.010
|
2010-12-15
|
2010-08-27
|
0.010
|
2010-09-15
|
2010-05-27
|
0.010
|
2010-06-15
|
2010-02-26
|
0.010
|
2010-03-15
|
2009-11-27
|
0.010
|
2009-12-15
|
2009-08-28
|
0.010
|
2009-09-15
|
2009-05-29
|
0.010
|
2009-06-15
|
2009-02-27
|
0.06
|
2009-03-13
|
2008-11-28
|
0.06
|
2008-12-15
|
2008-08-28
|
0.19
|
2008-09-15
|
2008-05-22
|
0.38
|
2008-06-13
|
2008-02-29
|
0.38
|
2008-03-14
|
2007-11-23
|
0.37
|
2007-12-14
|
2007-08-24
|
0.37
|
2007-09-14
|
2007-05-24
|
0.37
|
2007-06-15
|
2007-02-23
|
0.37
|
2007-03-15
|
2006-11-24
|
0.34
|
2006-12-15
|
2006-08-25
|
0.34
|
2006-09-15
|
2006-05-25
|
0.34
|
2006-06-15
|
2006-02-24
|
0.34
|
2006-03-15
|
2005-11-25
|
0.32
|
2005-12-15
|
2005-08-26
|
0.32
|
2005-09-15
|
2005-05-26
|
0.32
|
2005-06-15
|
2005-02-25
|
0.32
|
2005-03-15
|
2004-11-26
|
0.31
|
2004-12-13
|
2004-08-27
|
0.31
|
2004-09-15
|
2004-05-27
|
0.31
|
2004-06-15
|
2004-02-27
|
0.31
|
2004-03-15
|
2003-11-28
|
0.31
|
2003-12-12
|
2003-08-28
|
0.31
|
2003-09-15
|
2003-06-02
|
0.31
|
2003-06-16
|
2003-02-28
|
0.31
|
2003-03-14
|
2002-11-29
|
0.30
|
2002-12-13
|
2002-08-23
|
0.30
|
2002-09-13
|
2002-05-30
|
0.30
|
2002-06-14
|
2002-03-01
|
0.30
|
2002-03-15
|
2001-11-23
|
0.29
|
2001-12-14
|
2001-08-24
|
0.29
|
2001-09-15
|
2001-05-24
|
0.29
|
2001-06-15
|
2001-02-23
|
0.29
|
2001-03-15
|
2000-11-24
|
0.28
|
2000-12-15
|
2000-08-25
|
0.28
|
2000-09-15
|
2000-05-25
|
0.28
|
2000-06-15
|
2000-02-25
|
0.28
|
2000-03-15
|
1999-12-01
|
0.26
|
1999-12-15
|
1999-08-27
|
0.26
|
1999-09-15
|
1999-05-27
|
0.26
|
1999-06-15
|
1999-02-26
|
0.26
|
1999-03-15
|
1998-11-27
|
0.23
|
1998-12-15
|
1998-08-28
|
0.23
|
1998-09-15
|
1998-05-29
|
0.23
|
1998-06-15
|
1998-02-12
|
0.47
|
1998-02-27
|
1997-11-28
|
0.42
|
1997-12-15
|
1997-08-28
|
0.42
|
1997-09-15
|
1997-05-22
|
0.42
|
1997-06-13
|
1997-02-28
|
0.42
|
1997-03-14
|
1996-11-29
|
0.38
|
1996-12-13
|
1996-08-23
|
0.38
|
1996-09-13
|
1996-05-31
|
0.38
|
1996-06-14
|
1996-02-23
|
0.38
|
1996-03-15
|
1995-11-24
|
0.36
|
1995-12-15
|
1995-08-25
|
0.36
|
1995-09-15
|
1995-05-23
|
0.36
|
1995-06-15
|
1995-02-22
|
0.36
|
1995-03-15
|
1994-11-25
|
0.32
|
1994-12-15
|
1994-08-25
|
0.32
|
1994-09-15
|
1994-05-24
|
0.32
|
1994-06-15
|
1994-02-22
|
0.32
|
1994-03-15
|
1993-11-23
|
0.28
|
1993-12-15
|
1993-08-25
|
0.28
|
1993-09-15
|
1993-05-25
|
0.28
|
1993-06-15
|
1993-02-24
|
0.56
|
1993-03-15
|
1992-11-24
|
0.49
|
1992-12-15
|
1992-08-26
|
0.49
|
1992-09-15
|
1992-05-27
|
0.49
|
1992-06-15
|
1992-02-26
|
0.49
|
1992-03-13
|
1991-11-26
|
0.46
|
1991-12-13
|
1991-08-27
|
0.46
|
1991-09-13
|
1991-05-21
|
0.46
|
1991-06-14
|
1991-02-27
|
0.46
|
1991-03-15
|
1990-11-20
|
0.44
|
1990-12-14
|
1990-08-22
|
0.44
|
1990-09-14
|
1990-05-22
|
0.44
|
1990-06-15
|
1990-02-28
|
0.44
|
1990-03-15
|
1989-11-21
|
0.40
|
1989-12-15
|
1989-08-23
|
0.40
|
1989-09-15
|
1989-05-23
|
0.40
|
1989-06-15
|
1989-02-22
|
0.40
|
1989-03-15
|
1988-11-22
|
0.34
|
1988-12-15
|
1988-08-24
|
0.34
|
1988-09-15
|
1988-05-24
|
0.34
|
1988-06-15
|
1988-02-24
|
0.34
|
1988-03-15
|
1987-11-24
|
0.30
|
1987-12-15
|
1987-08-26
|
0.30
|
1987-09-15
|
1987-05-27
|
0.30
|
1987-06-15
|
1987-02-25
|
0.30
|
1987-03-16
|
1986-11-25
|
0.48
|
1986-12-15
|
1986-08-26
|
0.48
|
1986-09-15
|
1986-05-28
|
0.48
|
1986-06-16
|
1986-02-26
|
0.48
|
1986-03-15
|
1985-11-26
|
0.46
|
1985-12-16
|
1985-08-29
|
0.46
|
1985-09-16
|
1985-05-29
|
0.46
|
1985-06-15
|
1985-02-27
|
0.46
|
1985-03-15
|
1984-11-20
|
0.43
|
1984-12-15
|
1984-08-22
|
0.43
|
1984-09-15
|
1984-05-22
|
0.43
|
1984-06-15
|
1984-02-22
|
0.43
|
1984-03-15
|
1983-11-22
|
0.40
|
1983-12-15
|
1983-08-24
|
0.40
|
1983-09-15
|
1983-05-24
|
0.40
|
1983-06-15
|
1983-02-23
|
0.40
|
1983-03-15
|
1982-11-18
|
0.38
|
1982-12-15
|
1982-08-18
|
0.38
|
1982-09-15
|
1982-05-19
|
0.38
|
1982-06-15
|
1982-02-17
|
0.38
|
1982-03-15
|
1981-11-18
|
0.36
|
1981-12-15
|
1981-08-19
|
0.36
|
1981-09-15
|
1981-05-19
|
0.36
|
1981-06-15
|
1981-02-18
|
0.36
|
1981-03-16
|
1980-11-19
|
0.33
|
1980-12-15
|
1980-08-20
|
0.33
|
1980-09-15
|
1980-05-20
|
0.33
|
1980-06-16
|
1980-02-20
|
0.33
|
1980-03-14
|
1979-11-20
|
0.30
|
1979-12-15
|
1979-08-22
|
0.30
|
1979-09-15
|
1979-05-16
|
0.30
|
1979-06-15
|
1979-02-21
|
0.30
|
1979-03-15
|
1978-11-21
|
0.28
|
1978-12-15
|
1978-08-16
|
0.55
|
1978-09-15
|
1978-05-17
|
0.50
|
1978-06-15
|
1978-02-22
|
0.50
|
1978-03-15
|
1977-11-16
|
0.45
|
1977-12-15
|
1977-08-17
|
0.45
|
1977-09-15
|
1977-05-18
|
0.45
|
1977-06-15
|
1977-02-15
|
0.45
|
1977-03-15
|
